The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.
Katharine Jenner, Campaign Director and Mhairi Brown, Policy and Public Affairs Manager of Action on Sugar and Action on Salt debate who should be responsible for tackling the biggest cause of premature death and disability in the UK when Public Health England is dissolved.
Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of infection prevention and control in the healthcare sector in light of COVID-19.
Open Access Government takes a look at the ways in which Olivier Véran, the French Minister for Health and Solidarity, has supported French citizens through a health crisis and beyond.
Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.
Timothy Kwok, Professor at The Chinese University of Hong Kong, tells us about the Electronic Cognitive Screen (EC-Screen) that gives a brief and user-friendly digital cognitive test for the detection of dementia in older people.
Mental Health Europe point out that the New Pact on Migration and Asylum leaves behind migrants with disabilities and mental health problems, suggesting how this oversight could be resolved.
SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.
The rise of the virtual ward is charted here by Max Mckiernan, L2S2’s Marketing Manager and Jane Aldridge, Co-Founder/CBDO/CFO, including analysis of why COVID may save the NHS.
Here, we discover that SymlConnect digitises the paper-processes, offering remote monitoring to improve efficiency in care monitoring and reducing the waiting list exacerbated by the COVID-19 pandemic.
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
